Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Associ
about
sameAs
A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki diseasePathogenesis and management of Kawasaki diseaseMedium-size-vessel vasculitisPediatric vasculitisKawasaki disease presenting as parotitis in a 3-month-old infantRelationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki diseaseEULAR/PReS endorsed consensus criteria for the classification of childhood vasculitidesUse of corticosteroids during acute phase of Kawasaki diseaseRecurrent Kawasaki disease in a child with retropharyngeal involvement: a case report and literature reviewCervical lymph node diseases in childrenKawasaki Disease: A Clinician's UpdateCan Kawasaki disease be managed?Kawasaki disease for dermatologistsThe effect of TNFalpha blockade in complicated, refractory Kawasaki diseaseCalcified occlusion of the right coronary artery in Kawasaki disease: evidence of myocardial ischaemia using cardiac technetium-99m-tetrofosmin perfusion single-photon emission computed tomographyKawasaki disease: diagnosis, management and cardiac sequelaeThe diagnosis and management of Kawasaki diseaseA case of myocardial infarction complicating Kawasaki diseaseHigh-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki DiseaseIdentification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association studyTwo new susceptibility loci for Kawasaki disease identified through genome-wide association analysis.Gastrointestinal aspects of vasculitides.Application of prospective ECG-triggered dual-source CT coronary angiography for infants and children with coronary artery aneurysms due to Kawasaki disease.Observational study of Interleukin-21 (IL-21) does not distinguish Kawasaki disease from other causes of fever in children.Kawasaki disease in children and adolescents: clinical data of Kawasaki patients in a western region (Tyrol) of Austria from 2003-2012Reversible splenial lesion syndrome associated with lobar pneumonia: Case report and review of literature.Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness.Vascular function long term after Kawasaki disease: another piece of the puzzle?The relationship between hematological findings and coronary artery aneurysm in kawasaki diseaseIs dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europeKawasaki disease in infants below 6 months: a clinical conundrum?Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children.Pustulovesicular Skin Eruption as Presenting Feature of Incomplete Kawasaki DiseaseEffectiveness of Medium-Dose Intravenous Immunoglobulin (1 g/kg) in the Treatment of Kawasaki Disease.Conjunctivitis: a systematic review of diagnosis and treatmentPeriostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarker.ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki diseaseIn Vitro Validation of Patient-Specific Hemodynamic Simulations in Coronary Aneurysms Caused by Kawasaki Disease.High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.
P2860
Q21563323-221D25D9-CDB2-4227-9522-0F05C05D69C0Q22305933-CA3AD21B-4152-4EAF-B4B4-94E5A1C5060FQ24604335-2213043B-A210-477F-A5D5-783EC7E11B05Q24625167-1A42AB21-5025-4391-9763-0B66BA63012CQ24644837-79830492-189A-4A8C-9067-A8F7653CD507Q24675119-0B11EAF6-330B-44E7-A2F8-A0D360E73218Q24675246-79699C83-0BB2-48CA-873E-E3769ABA8689Q26777190-8E8F01D4-3C2B-4182-A21E-8046BEC942E3Q26863446-0637484C-3200-4CAC-9C38-ED64FD88DBC6Q26865114-EC90976D-C4D5-4BF8-8E41-FBA0C031C190Q26998791-592712E3-6CF2-4E0C-9951-6D7527A92497Q27022010-87537A87-5AF9-4707-AC19-E0E669C3C0E2Q28073137-DA33EEF5-69E9-4C9B-91A2-621CB93498CFQ28199924-5A1BD83E-A5DB-418E-9576-BBB6B1224D1FQ28200903-86DC9F53-01A7-4334-B351-363C3DBCF0FCQ28210070-1453F2CD-C374-4EDB-89EE-AD41311D24C5Q28211402-DE2D45A0-A644-41B6-936C-D560E30B24CDQ28219314-637A862A-C57B-4FFA-AB22-DE0AFBB04E64Q28396984-1FA71571-BBFB-47BD-B074-5AA51A6B5180Q28943550-9748679B-F084-4746-9582-EA57B8E9CF66Q29417067-7ACB5F37-02F5-4376-B092-88BE43AD015BQ30240787-61237778-11F9-4FDF-BAB0-C3D5AE7204D3Q30446491-637930FF-D33D-4432-B7A5-A5444CB452CDQ30846279-A85336D7-DEAD-4790-9500-8D65A962DB81Q31131656-A5E5661C-4DBA-4A75-BE3F-D9BE3C2F1E73Q31133742-B4A0369D-EBF0-4887-990B-393ED16D85C0Q33333142-0FAC650B-9674-4212-B0E0-A2BFFB2FA5CDQ33365295-87E2C598-952F-4BBE-B7E8-00288BFFD4F5Q33416509-2DFB9419-C21C-43CB-8D3D-727FA674B83CQ33419638-A6260B77-149B-4A2B-AA6B-15DDA0261C7FQ33430840-E76EDC2E-17DD-492D-B5F3-63235D80F24BQ33619503-4C63F593-91AF-4B4E-9667-08034E3C4048Q33652518-AA080E70-65AA-42CD-AD85-FB8FC3A0790BQ33685026-412C8D91-A6D2-453F-89CD-88CAB18ECD00Q33726882-8A97DE96-AB4F-4741-9BF1-9C185116E133Q33864138-1877896B-A37C-4BBC-B720-4A97B21A9FABQ33886535-682FD586-D97E-4B6D-95F6-888635D27C99Q33917055-B96C6D54-8F99-4240-A844-68D58FF1310BQ33919082-ED495EFA-A482-443D-9499-0413B50C082EQ33921997-B5871D82-65BD-40A7-94A6-6D110C0F0B6B
P2860
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Associ
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Diagnosis, treatment, and long ...... e Young, American Heart Associ
@nl
type
label
Diagnosis, treatment, and long ...... e Young, American Heart Associ
@nl
prefLabel
Diagnosis, treatment, and long ...... e Young, American Heart Associ
@nl
P2093
P3181
P356
P1433
P1476
Diagnosis, treatment, and long ...... ng, American Heart Association
@en
P2093
Ann F Bolger
Donald A Falace
Jane C Burns
Kathryn A Taubert
Larry M Baddour
Lloyd Y Tani
Masato Takahashi
Matthew E Levison
Michael A Gerber
Michael H Gewitz
P304
P3181
P356
10.1542/PEDS.2004-2182
P407
P577
2004-12-01T00:00:00Z